Khondrion Ip B V
USPTO Trademark & Patent Filings
Trademark applications and grants for Khondrion Ip B V. Khondrion Ip B V has 2 trademark applications. The latest application filed is for "VIVOXYL"
| Patent Application | Date |
|---|---|
| Novel compounds for use in treating depression and migraine 20220273636 - 17/742417 Smeitink; Johannes Albertus Maria ; et al. | 2022-09-01 |
| Treatment of mitochondrial diseases 20220265604 - 17/672731 Beyrath; Julien David ; et al. | 2022-08-25 |
| Novel treatment of mitochondrial diseases 20210113520 - 16/500437 Beyrath; Julien David ; et al. | 2021-04-22 |
| Novel compounds for treating mitochondrial disease 20210024484 - 17/024727 Beyrath; Julien David ; et al. | 2021-01-28 |
| Compounds as mPGES-1 inhibitors 20200345706 - 16/765169 Smeitink; Johannes Albertus Maria ; et al. | 2020-11-05 |
Mark Image Registration | Serial | Trademark Application Date |
|---|---|
"VIVOXYL" 5911358 79257479 |
VIVOXYL 2019-02-27 |
"KHONDRION" 5126244 79179589 |
KHONDRION 2015-10-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 